Hypertension, RenalHyperlipidemia, Familial CombinedHyperlipidemiasHypertensionHypertension, RenovascularBlood PressureReninHypertension, PulmonaryRenal ArterySaralasinAngiotensin IIKidneyRenal Artery ObstructionTriglyceridesPressoreceptorsRats, Inbred StrainsHypolipidemic AgentsVascular ResistanceLipidsCholesterolNephrectomyCardiomegalyHypertension, PortalHemodynamicsLigationAntihypertensive AgentsDogsHeart RateNorepinephrineRisk FactorsHypertriglyceridemiaCholesterol, LDLHypercholesterolemiaHyperlipoproteinemia Type IVLipoproteinsApolipoproteins EHypertension, MalignantRabbitsLipid MetabolismCholesterol, HDLMyocardiumApolipoproteins BApolipoproteins CApolipoprotein E2ObesityApolipoprotein C-IIIFenofibrateLipoprotein LipaseArteriosclerosisXanthomatosisLipoproteins, VLDLAnticholesteremic AgentsDiabetes MellitusHydroxymethylglutaryl-CoA Reductase InhibitorsLiverCardiovascular DiseasesApolipoproteinsLipoproteins, LDLDisease Models, AnimalCholesterol, VLDLAtherosclerosisDietary FatsGynostemmaBody WeightHyperlipoproteinemia Type IIHypertension, Pregnancy-InducedReceptors, LDLBlood GlucoseDiabetes Mellitus, Type 2DyslipidemiasPrevalenceInsulin ResistanceHyperlipoproteinemia Type IIITime FactorsMice, Inbred C57BLPoloxamerHeptanoic AcidsTreatment OutcomeDiet, AtherogenicOcular HypertensionApolipoprotein A-I